nightware

NightWare Secures Strategic Series C Investment from Exit 156 Capital to Scale FDA-Cleared Digital Therapeutic for PTSD-Related Nightmare Disorder

NightWare Inc., a pioneer in the digital therapeutics sector, has entered into a strategic partnership with Exit 156 Capital, marking…